Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
DOI
PMC
 |
|
|
Open Access Gold möglich sobald Verlagsversion bei der ZB eingereicht worden ist.
Baseline fibroblast growth factor 23 is associated with long-term mortality in ST-elevation myocardial infarction-results from the augsburg myocardial infarction registry.
Front. Cardiovasc. Med. 10:1173281 (2023)
BACKGROUND: The aim of this study was to investigate the association between inflammatory plasma protein concentrations and long-term mortality in patients with ST-elevation myocardial infarction (STEMI). METHODS: For 343 STEMI patients recorded between 2009 and 2013 by the population-based Myocardial Infarction Registry Augsburg, 92 inflammatory plasma proteins were measured at the index event using the OLINK inflammation panel. In multivariable-adjusted Cox regression models, the association between each plasma protein and all-cause long-term mortality was investigated. Median follow-up time was 7.6 (IQR: 2.4) years. For plasma protein that showed a strong association with long-term mortality, a 5-year survival ROC analysis was performed. RESULTS: One plasma protein, namely Fibroblast Growth Factor 23 (FGF-23), was particularly well associated with long-term mortality in the multivariable-adjusted Cox model with an FDR-adjusted p-value of <0.001 and a Hazard Ratio (HR) of 1.57 [95% CI: 1.29-1.91]. In the 5-years ROC analysis, an AUC of 0.6903 [95% CI: 0.594-0.781] was estimated for FGF-23. All other plasma protein didńt show strong associations, each marker with FDR-adjusted p-values >0.05 in the multivariable-adjusted Cox models. CONCLUSIONS: FGF-23 is independently associated with long-term mortality after STEMI and might play an important role in the response to myocardial injury. The results suggest FGF-23 to be a useful marker in the long-term treatment of STEMI patients and a potential target for drug development.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Fgf-23 ; Stemi ; Inflammatory Plasma Protein ; Long-term Mortality ; Myocardial Infarction; Cardiovascular Events; Heart-failure; Ami-registry; Fgf23; Disease; Risk; Fgf-23; Monica/kora; Population; Biomarkers
ISSN (print) / ISBN
2297-055X
e-ISSN
2297-055X
Zeitschrift
Frontiers in Cardiovascular Medicine
Quellenangaben
Band: 10,
Artikelnummer: 1173281
Verlag
Frontiers
Verlagsort
Lausanne
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Epidemiology II (EPI2)
Förderungen
Medical Faculty of the University of Augsburg
BMBF (German Ministry of Education and Research)
DZHK (German Centre for Cardiovascular Research)
German Federal Ministry of Health
State of Bavaria
Helmholtz Zentrum Muenchen, German Research Center for Environmental Health - German Federal Ministry of Education, Science, Research and Technology
BMBF (German Ministry of Education and Research)
DZHK (German Centre for Cardiovascular Research)
German Federal Ministry of Health
State of Bavaria
Helmholtz Zentrum Muenchen, German Research Center for Environmental Health - German Federal Ministry of Education, Science, Research and Technology